Sign inGet started

Windham-Bannister Susan Richards

Insider CIK 1713760 · HSTO Director · ARDS Director · HUMA Director · CATC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HUMA Humacyte, Inc. A Award deriv2026-06-112026-06-1280,000— $080,000SEC↗
HUMA Humacyte, Inc. A Award deriv2025-06-122025-06-1680,000— $080,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2024-06-272024-06-28200,000— $0261,000SEC↗
HUMA Humacyte, Inc. A Award deriv2024-06-132024-06-1750,000— $050,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2023-09-182023-09-1915,000— $073,500SEC↗
HSTO Histogen Inc. A Award deriv2023-06-202023-06-216,835— $06,835SEC↗
HUMA Humacyte, Inc. A Award deriv2023-06-152023-06-168,500— $08,500SEC↗
ARDS Aridis Pharmaceuticals, In M Exercise deriv2023-06-052023-06-155,000— $05,000SEC↗
ARDS Aridis Pharmaceuticals, In M Exercise2023-06-052023-06-155,000— $05,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2023-05-042023-06-1515,000— $058,500SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2022-12-052022-12-0710,000— $010,000SEC↗
HUMA Humacyte, Inc. A Award deriv2022-06-092022-06-138,500— $08,500SEC↗
HSTO Histogen Inc. A Award deriv2022-06-012022-06-031,000— $01,000SEC↗
HUMA Humacyte, Inc. A Award deriv2021-10-132021-10-1513,000— $013,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2021-10-042021-10-058,500— $043,500SEC↗
HSTO Histogen Inc. A Award deriv2021-03-102021-03-1230,000— $030,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2019-07-122019-07-1535,000— $035,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2019-07-122019-08-2935,000— $035,000SEC↗
CATC CAMBRIDGE BANCORP A Award2018-06-202018-06-21347— $0347SEC↗